--

Lapatinib 250mg Tablets




Medicine Detail


Product Name: Tykerb

Contains: Lapatinib

Form: Tablets

Manufactured By: GSK

Strength: 250 mg

Packing: Pack of 42 Tablets (7*6)


Lapatinib is a physician endorsed medicate that is utilized to treat bosom malignancy. It's utilized as a part of mix with capecitabine or letrozole.Lapatinib comes as a tablet that you take by mouth.Lapatinib is accessible as the brand-name medicate Tykerb. It's not accessible as a non specific drug.


What is lapatinib Tykerb Tables? 

This medication is a professionally prescribed medication. It comes as a tablet you take by mouth. 

This medication is accessible as the brand-name tranquilize Tykerb. It is not accessible as a nonexclusive medication. 

This medication might be utilized as a major aspect of a blend treatment. That implies you may need to bring it with different medications to treat your condition. This medication might be endorsed with capecitabine or letrozole. 

Why it's Tykerb utilized 

This medication is utilized to treat bosom disease. It's utilized with a medication called capecitabine to treat progressed or metastatic bosom disease that is HER2-positive (has a protein in your body). It's utilized when certain other bosom malignancy medicines have not worked. It's likewise utilized with a medication called letrozole to treat hormone receptor-positive, HER2-positive metastatic bosom malignancy in postmenopausal ladies who require hormonal treatment. 

How it functions 

This medication has a place with a medication class called kinase inhibitors. A class of medications alludes to drugs that work comparably. These medications are regularly used to treat comparative conditions. 

This medication works by obstructing the activity of specific proteins called kinases that advise tumor cells in your body to increase. This activity moderates or stop the spread of tumor cells in your body.

Write a review

Note: HTML is not translated!
    Bad           Good
Captcha

Tags: Tykerb 250 mg, Lapatinib Tablets, breast cancer medicine